Kura Oncology, Inc. (KURA)

Revance Therapeutics Revenue

Kura Oncology had revenue of $14.11M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $67.99M. In the year 2024, Kura Oncology had annual revenue of $53.88M.

• Revenue (ttm): $67.99M
• Revenue Growth: n/a
• P/S Ratio: 7.71
• Revenue / Employee: $354,120
• Employees: 192
• Market Cap: 521.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.88M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.